Analysis of treatment outcomes in sarcoma patients
A Single-center Retrospective Study of Clinical Features, Treatment Patterns, and Survival of Sarcomas
This study looks at the treatment results of sarcoma patients over ten years to see how different therapies affect their recovery and survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Ages | 6 Years to 99 Years |
| Sex | All |
| Sponsor | Henan Cancer Hospital Government |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Zhengzhou, Henan) |
| Trial ID | NCT05453409 on ClinicalTrials.gov |
What this trial studies
This observational study collects and analyzes clinical data from patients diagnosed with sarcoma who received various treatments at Henan Tumor Hospital over a ten-year period. It focuses on the efficacy, recurrence rates, and survival outcomes associated with chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy, and surgical interventions. By retrospectively reviewing patient records, the study aims to identify patterns and outcomes that can inform future treatment strategies for sarcoma.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with a specific subtype of sarcoma who have received treatment at Henan Tumor Hospital.
Not a fit: Patients without a clear pathology diagnosis or those with incomplete follow-up data may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the most effective treatment modalities for sarcoma, potentially improving patient outcomes.
How similar studies have performed: Other studies have shown success in analyzing treatment outcomes for sarcoma, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: No age limit, male or female. A certain subtype of sarcoma was diagnosed by pathology in our hospital. Has received at least one hospitalization in this hospital. Target lesions can be evaluated according to solid tumor efficacy evaluation criteria (RECIST; Version 1.1) Measure diameter changes. Complete follow-up data. Exclusion Criteria: No clear pathology. Incomplete follow-up data.
Where this trial is running
Zhengzhou, Henan
- Department of Bone and Soft Tissue ,Henan Cancer Hospital — Zhengzhou, Henan, China (Recruiting)
Study contacts
- Study coordinator: Wang Jiaqiang, Dr.
- Email: wjqwtj@126.com
- Phone: 13592413731
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.